Mode
Text Size
Log in / Sign up
N/A N=1,578 Randomized Single-blind Prevention

The Impact of Cigarillo Warnings on Purchasing

Cigar Smoking

Enrolled (actual)
1,578
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcome: Primary: Average Total Number of Cigarillos Purchased — 6.33; 6.28; 6.64; 4.98 cigarillos

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Cigarillo warnings-Surgeon General Text-Only (Behavioral); Cigarillo warnings-FDA proposed text-only (Behavioral); Cigarillo warnings-Pictorial (Behavioral)
Age
Adult · 21+ yrs
Sex
All
Sponsor
Boston University
Primary completion
Jul 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Average Total Number of Cigarillos Purchased
6.33; 6.28; 6.64; 4.98; 6.45; 6.14
SECONDARY
Average Total Amount of mg Combusted Tobacco Purchased
445.06; 404.52; 395.66; 339.39; 416.61; 401.25
SECONDARY
Average Total Amount of mg Non-combusted Tobacco Purchased
134.81; 133.72; 148.93; 106.68; 122.98; 126.93
SECONDARY
Intensity Index for Cigarillos
6.33; 6.28; 6.64
SECONDARY
Cost Related Indices for Cigarillos
8.91; 9.89; 9.47; 6.05; 6.40; 6.37
SECONDARY
Rate of Change for Cigarillo Demand
0.03; 0.02; 0.03

Summary

The purpose of this study is to determine whether different cigarillo warning formats (pictorial, FDA-proposed text-only, current Surgeon General text-only) reduces demand for cigarillos. A previous study has identified that pictorial cigarillo warnings are perceived as more effective, but more information is needed on their impact. This study will address this issue by randomizing participants to see different cigarillo warning formats on cigarillo products within an online experimental tobacco marketplace. Participants will be cigarillo users who are ages 21-35.

Eligibility Criteria

Inclusion Criteria

  • Current cigarillo users: used cigarillos at least one time per week in the past month
  • Members of the Kantar Media panel

Exclusion Criteria

  • Non-English speakers
  • Non-current cigarillo users
  • Not members of Kantar Media
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05434013). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search